M2/ANXA5 haplotype as a predisposition factor in Malay women and couples experiencing recurrent spontaneous abortion: a pilot study. Issue 4 (April 2015)

• Record Type: Journal Article
• Authors: Thean Hock, Tang; Bogdanova, Nadja; Kai Cheen, Ang; Kathirgamanathan, Sushilnathan; bin Abdullah, Ridzuan; Mohd Yusoff, Narazah; Zaidah Abdullah, Wan; Syima Abdul Manaf, Faizatul; Wieacker, Peter; Markoff, Arseni
• Is Part Of: Reproductive biomedicine online. Volume 30:Issue 4(2015)
• Page Start: 434
• Page End: 439
• Publication Date: 2015-04
• Subjects: Human reproductive technology -- Periodicals; Human embryo -- Periodicals; Reproduction -- Periodicals; 616.692
• DOI: 10.1016/j.rbmo.2014.12.014
• Languages: English
• ISSNs: 1472-6483

Abstract

<abstract abstract-type="author" id="ab0010"> <title id="st0010">Abstract</title> <sec> <p id="sp0010">Recurrent spontaneous abortion (RSA) is a prevalent condition among the Malay population of Malaysia, where carriage risk of conventional hereditary thrombophilia factors has been generally ruled out. The contribution of <italic>M2/ANXA5</italic>, a common haplotype in the annexin A5 gene promoter, was evalauted for RSA in Malay. Seventy-seven women who had experienced two or more unexplained RSA and 41 available male partners were selected for study, with 360 population controls recruited from healthy Malay individuals. Incidence of M2 carriage and odds ratios were calculated between control and patient groups, and clinically defined subgroups and RSA risk was evaluated. <italic>M2/ANXA5</italic>, found in 42.2% of the general Malay population, was associated with greater risks for women with primary and secondary RSA with early (gestational week 5–15) losses. The risk was somewhat higher in Malay couples when both partners were carriers and a trend of higher prevalence was seen for the male partners patients who had experienced RSA. M2 carriage seems to be a risk factor with unusually high incidence in Malay women and couples with primary and secondary RSA with 'early' spontaneous abortions. The associated male partner risk confirms the proposed role of <italic>M2/ANXA5</italic> as a genetic trait impeding embryonic anticoagulation.</p> </sec> </abstract>